INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 171 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $12,000 | +33.3% | 532 | +50.7% | 0.00% | – |
| Q1 2021 | $9,000 | +50.0% | 353 | +54.8% | 0.00% | – |
| Q4 2020 | $6,000 | -25.0% | 228 | -0.4% | 0.00% | – |
| Q3 2020 | $8,000 | +700.0% | 229 | +1808.3% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 12 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -98.4% | 12 | -97.8% | 0.00% | -100.0% |
| Q1 2019 | $62,000 | -57.8% | 552 | -64.6% | 0.01% | -11.1% |
| Q4 2018 | $147,000 | -60.5% | 1,561 | -47.0% | 0.01% | -40.0% |
| Q3 2018 | $372,000 | +17.0% | 2,943 | -22.4% | 0.02% | +15.4% |
| Q2 2018 | $318,000 | +439.0% | 3,794 | +274.9% | 0.01% | +333.3% |
| Q1 2018 | $59,000 | 0.0% | 1,012 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $59,000 | -59.0% | 1,012 | -59.2% | 0.00% | -50.0% |
| Q3 2017 | $144,000 | -8.3% | 2,482 | +90.9% | 0.01% | -14.3% |
| Q2 2017 | $157,000 | +145.3% | 1,300 | +128.1% | 0.01% | +133.3% |
| Q1 2017 | $64,000 | +3.2% | 570 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $62,000 | -34.0% | 570 | 0.0% | 0.00% | -40.0% |
| Q3 2016 | $94,000 | +16.0% | 570 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $81,000 | +30.6% | 570 | +3.3% | 0.01% | -37.5% |
| Q1 2016 | $62,000 | -52.3% | 552 | -36.6% | 0.01% | -11.1% |
| Q4 2015 | $130,000 | – | 871 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |